These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34284824)

  • 1. Vibrio vulnificus induces the death of a major bacterial species in the mouse gut via cyclo-Phe-Pro.
    Kim JA; Jang BR; Kim YR; Jung YC; Kim KS; Lee KH
    Microbiome; 2021 Jul; 9(1):161. PubMed ID: 34284824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-κB pathway.
    Kim K; Kim NJ; Kim SY; Kim IH; Kim KS; Lee GR
    Infect Immun; 2015 Mar; 83(3):1150-61. PubMed ID: 25561711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclo(Phe-Pro) produced by Vibrio species passes through biological membranes by simple diffusion.
    Park NY; Cho YB; Kim OB; Kim KS
    Appl Microbiol Biotechnol; 2020 Aug; 104(15):6791-6798. PubMed ID: 32533306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo-(l-Phe-l-Pro), a Quorum-Sensing Signal of Vibrio vulnificus, Induces Expression of Hydroperoxidase through a ToxR-LeuO-HU-RpoS Signaling Pathway To Confer Resistance against Oxidative Stress.
    Kim IH; Kim SY; Park NY; Wen Y; Lee KW; Yoon SY; Jie H; Lee KH; Kim KS
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29914931
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of luxS encoding a synthase of quorum-sensing signal molecule AI-2 of Vibrio vulnificus on mouse gut microbiome.
    Lee KW; Jie H; Kim S; Baek MG; Yi H; Kim KS
    Appl Microbiol Biotechnol; 2022 May; 106(9-10):3721-3734. PubMed ID: 35488933
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu L; Xu M; Lan R; Hu D; Li X; Qiao L; Zhang S; Lin X; Yang J; Ren Z; Xu J
    Front Immunol; 2022; 13():1036196. PubMed ID: 36531989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine.
    You JS; Yong JH; Kim GH; Moon S; Nam KT; Ryu JH; Yoon MY; Yoon SS
    Microbiome; 2019 Sep; 7(1):132. PubMed ID: 31521198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp.
    Park DK; Lee KE; Baek CH; Kim IH; Kwon JH; Lee WK; Lee KH; Kim BS; Choi SH; Kim KS
    J Bacteriol; 2006 Mar; 188(6):2214-21. PubMed ID: 16513751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteroides vulgatus Ameliorates Lipid Metabolic Disorders and Modulates Gut Microbial Composition in Hyperlipidemic Rats.
    Xu M; Lan R; Qiao L; Lin X; Hu D; Zhang S; Yang J; Zhou J; Ren Z; Li X; Liu G; Liu L; Xu J
    Microbiol Spectr; 2023 Feb; 11(1):e0251722. PubMed ID: 36625637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic analysis of genes modulated by cyclo(L-phenylalanine-L-proline) in Vibrio vulnificus.
    Kim IH; Son JS; Wen Y; Jeong SM; Min GY; Park NY; Lee KW; Cho YJ; Chun J; Kim KS
    J Microbiol Biotechnol; 2013 Dec; 23(12):1791-801. PubMed ID: 24100622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of different
    Wang C; Xiao Y; Yu L; Tian F; Zhao J; Zhang H; Chen W; Zhai Q
    J Adv Res; 2022 Feb; 36():27-37. PubMed ID: 35127162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibrio vulnificus infection induces the maturation and activation of dendritic cells with inflammatory Th17-polarizing ability.
    Lee A; Lim HX; Kim MS; Cho D; Jang KK; Choi SH; Kim TS
    Int J Mol Med; 2018 Jan; 41(1):531-540. PubMed ID: 29115398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro and in vivo efficacy of hen IgY against Vibrio parahaemolyticus and Vibrio vulnificus.
    Kassim N; Mtenga AB; Shim WB; Chung DH
    J Microbiol Biotechnol; 2012 Oct; 22(10):1423-31. PubMed ID: 23075795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus.
    Lee B; Park J; Ryu M; Kim S; Joo M; Yeom JH; Kim S; Park Y; Lee K; Bae J
    Sci Rep; 2017 Oct; 7(1):13572. PubMed ID: 29051620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.
    Lee TH; Cha SS; Lee CS; Rhee JH; Chung KM
    Infect Immun; 2014 Nov; 82(11):4813-23. PubMed ID: 25156730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity.
    Lee W; Lee SH; Kim M; Moon JS; Kim GW; Jung HG; Kim IH; Oh JE; Jung HE; Lee HK; Ku KB; Ahn DG; Kim SJ; Kim KS; Oh JW
    Nat Commun; 2018 Apr; 9(1):1606. PubMed ID: 29686409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
    Trinh SA; Gavin HE; Satchell KJF
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive small molecules produced by the human gut microbiome modulate
    Pauer H; Teixeira FL; Robinson AV; Parente TE; De Melo MAF; Lobo LA; Domingues RMCP; Allen-Vercoe E; Ferreira RBR; Antunes LCM
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 34006192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual expression of transgenic delta-5 and delta-6 desaturase in tilapia alters gut microbiota and enhances resistance to Vibrio vulnificus infection.
    Chiang KY; Lin WC; Tsai TY; Lin CW; Huang SJ; Huang CY; Wu SH; Ken CF; Gong HY; Chen JY; Wu JL
    PLoS One; 2020; 15(7):e0236601. PubMed ID: 32730353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.